Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Hematological Malignancies
Related studies linked through entity extraction aliases.
Compassionate Use Study of Tenalisib (RP6530)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy Evaluation of IM19 Cells
- Status
- UNKNOWN
- Phase
- PHASE1
Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells
- Status
- RECRUITING
- Phase
- PHASE3
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.
- Status
- COMPLETED
- Phase
- PHASE2
Study of IV CBL0137 in Previously Treated Hematological Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)
- Status
- COMPLETED
- Phase
- N/A
T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Impact of Child Positioning on Pain During a Lumbar Puncture
- Status
- COMPLETED
- Phase
- NA
Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib
- Status
- COMPLETED
- Phase
- N/A
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
- Status
- COMPLETED
- Phase
- PHASE3
Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Molecular Disease Profile of Hematological Malignancies
- Status
- UNKNOWN
- Phase
- N/A